Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ecke

Showing results (381-390 of 432) with videos related to

Pageof 44
Sort By:
JAMA Cardiology|December 20, 2018
Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart FailureLena Dorsheimer, Birgit Assmus, Tina Rasper, et al.
European Urology Oncology|January 10, 2021
PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate CancerThomas Steuber, Isabel Heidegger, Mona Kafka, et al.
International Journal of Surgery (London, England)|April 19, 2017
Registry of implants for the reconstruction of pelvic floor in males and females: A feasibility case seriesDimitri Barski, Holger Gerullis, Thorsten Ecke, et al.
Molecular Ecology|November 1, 2022
Urban forest soils harbour distinct and more diverse communities of bacteria and fungi compared to less disturbed forest soilsTiffany Scholier, Anton Lavrinienko, Ilze Brila, et al.
BJU International|June 26, 2024
Real-world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trialIngmar Wolff, Anton P Kravchuk, Ralph M Wirtz, et al.
International Journal of Molecular Sciences|July 27, 2022
Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene AssessmentThorsten H Ecke, Paula Carolin Voß, Thorsten Schlomm, et al.
Urologic Oncology|February 25, 2024
Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancerNatalya Benderska-Söder, Thorsten Ecke, Lisa Kleinlein, et al.
Clinical Chemistry|March 9, 2010
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancersCatharine M Sturgeon, Michael J Duffy, Barry R Hofmann, et al.
Clinical Genitourinary Cancer|April 28, 2026
Digital PCR-Based Uromonitor for Molecular Detection of Bladder Cancer: A Multicenter Validation Study Comparing Quantitative PCR and Urine CytologyAnton Kravchuk, Julio Ruben Rodas Garzaro, Ralph Wirtz, et al.
Parasites & Vectors|June 30, 2019
Anaplasma phagocytophilum evolves in geographical and biotic niches of vertebrates and ticksRyanne I Jaarsma, Hein Sprong, Katsuhisa Takumi, et al.
Pageof 44

Showing results (381-390 of 432) with videos related to

Sort By:
Pageof 44
JAMA Cardiology|December 20, 2018
Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart FailureLena Dorsheimer, Birgit Assmus, Tina Rasper, et al.
European Urology Oncology|January 10, 2021
PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate CancerThomas Steuber, Isabel Heidegger, Mona Kafka, et al.
International Journal of Surgery (London, England)|April 19, 2017
Registry of implants for the reconstruction of pelvic floor in males and females: A feasibility case seriesDimitri Barski, Holger Gerullis, Thorsten Ecke, et al.
Molecular Ecology|November 1, 2022
Urban forest soils harbour distinct and more diverse communities of bacteria and fungi compared to less disturbed forest soilsTiffany Scholier, Anton Lavrinienko, Ilze Brila, et al.
BJU International|June 26, 2024
Real-world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trialIngmar Wolff, Anton P Kravchuk, Ralph M Wirtz, et al.
International Journal of Molecular Sciences|July 27, 2022
Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene AssessmentThorsten H Ecke, Paula Carolin Voß, Thorsten Schlomm, et al.
Urologic Oncology|February 25, 2024
Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancerNatalya Benderska-Söder, Thorsten Ecke, Lisa Kleinlein, et al.
Clinical Chemistry|March 9, 2010
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancersCatharine M Sturgeon, Michael J Duffy, Barry R Hofmann, et al.
Clinical Genitourinary Cancer|April 28, 2026
Digital PCR-Based Uromonitor for Molecular Detection of Bladder Cancer: A Multicenter Validation Study Comparing Quantitative PCR and Urine CytologyAnton Kravchuk, Julio Ruben Rodas Garzaro, Ralph Wirtz, et al.
Parasites & Vectors|June 30, 2019
Anaplasma phagocytophilum evolves in geographical and biotic niches of vertebrates and ticksRyanne I Jaarsma, Hein Sprong, Katsuhisa Takumi, et al.
Pageof 44